AL Amyloidosis MOA Animation

Created for Prothena

axs-studio-al-amyloidosis-mechanism-of-action-moa-animation-01

axs-studio-al-amyloidosis-mechanism-of-action-moa-animation-02

The project

We created 3 short MOA/MOD animations for Prothena to highlight therapeutic areas targeted by their three lead molecules. A clear visual style and concise storytelling convey the key points.

Created for
Prothena

Mechanism of Action Animation

axs-studio-transdermal-opioid-analgesic-mechanism-of-action-moa-animation-01

Transdermal Opioid Analgesic Animation

Purdue Pharma; Abelson Taylor

axs-studio-liver-transplant-mTOR-everolimus-mechanism-of-action-moa-animation-01

mTOR Inhibition in Liver Transplantation Animation

Biopharmaceutical client

axs-studio-cystic-fibrosis-mechanism-of-disease-mod-animation-01

Kalydeco Cystic Fibrosis Animation

Vertex Pharmaceuticals; BioScience Communications

axs-studio-osteoporosis-osteoarthritis-calcitonin-mechanism-of-action-moa-animation-01

Osteoporosis Osteoarthritis Animation

Novartis; BioScience Communications

AL Amyloidosis MOA Animation

Prothena

axs-studio-IL-17-antagonist-secukinumab-mechanism-of-action-moa-animation-01

Secukinumab MOA Animation

Novartis; BioScience Communications

COVID-19 Update:
In alignment with public health directives, we continue to prioritize the safety of our staff and uninterrupted service to our clients.
We are open for business. Wishing you good health and resilience. We’re all in this together.

AL Amyloidosis MOA Animation

More